Unicycive Therapeutics (UNCY) Earnings Date, Estimates & Call Transcripts $0.58 -0.01 (-1.01%) Closing price 03:59 PM EasternExtended Trading$0.59 +0.01 (+2.24%) As of 04:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Unicycive Therapeutics Earnings Summary Unicycive Therapeutics released Q1 2025 earnings on May 14, 2025, reporting an EPS of -$0.05, which beat the consensus estimate of -$0.14 by $0.09. With a trailing EPS of -$0.51, Unicycive Therapeutics' earnings are expected to grow next year, from ($0.23) to ($0.08) per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportLatest Q1 2025 Earnings DateMay. 14EstimatedConsensus EPS (May. 14) -$0.14 Actual EPS (May. 14) -$0.05 Beat By $0.09 Get Unicycive Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Unicycive Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataUNCY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.UNCY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Unicycive Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.30-$0.08-$0.18Q2 20253-$0.11-$0.07-$0.09Q3 20253-$0.09-$0.03-$0.06Q4 20253-$0.03$0.14$0.08 FY 2025 12 -$0.53 -$0.04 -$0.24 Q1 20261$0.27$0.27$0.27Q2 20261$0.29$0.29$0.29Q3 20261$0.37$0.37$0.37Q4 20261$0.47$0.47$0.47 Unicycive Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025-$0.14-$0.05+$0.09-$0.05--3/27/2025Q4 2024-$0.13-$0.26 -$0.13-$0.26--8/14/2024Q2 2024-$0.23-$0.15+$0.08-$0.15--5/13/2024Q1 2024-$0.18-$0.27 -$0.09$0.07--3/28/2024Q4 2023-$0.18-$0.16+$0.02-$0.16--11/14/2023Q3 2023-$0.13-$0.13--$0.13--8/14/2023Q2 2023-$0.39-$0.29+$0.10-$0.29-- Unicycive Therapeutics Earnings - Frequently Asked Questions When did Unicycive Therapeutics announce their last quarterly earnings? Unicycive Therapeutics (NASDAQ:UNCY) last announced its quarterly earning data on Wednesday, May 14, 2025. Learn more on UNCY's earnings history. Did Unicycive Therapeutics beat their earnings estimates last quarter? In the previous quarter, Unicycive Therapeutics (NASDAQ:UNCY) reported ($0.05) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.14) by $0.09. Learn more on analysts' earnings estimate vs. UNCY's actual earnings. How much revenue does Unicycive Therapeutics generate each year? Unicycive Therapeutics (NASDAQ:UNCY) has a recorded annual revenue of $680,000.00. How much profit does Unicycive Therapeutics generate each year? Unicycive Therapeutics (NASDAQ:UNCY) has a recorded net income of -$30.54 million. UNCY has generated -$0.51 earnings per share over the last four quarters. What is Unicycive Therapeutics's EPS forecast for next year? Unicycive Therapeutics's earnings are expected to grow from ($0.23) per share to ($0.08) per share in the next year. More Earnings Resources from MarketBeat Related Companies 2seventy bio Earnings Date Terns Pharmaceuticals Earnings Date Palvella Therapeutics Earnings Date Inozyme Pharma Earnings Date Lifecore Biomedical Earnings Date Atea Pharmaceuticals Earnings Date Neurogene Earnings Date Monte Rosa Therapeutics Earnings Date ADC Therapeutics Earnings Date Corvus Pharmaceuticals Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles e.l.f. Beauty Sees Record Surge After Earnings, Rhode DealCrowdStrike Stock Slips: Analyst Downgrades Before Earnings Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsAdvance Auto Parts: Did Earnings Defuse Tariff Concerns?Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the Stock This page (NASDAQ:UNCY) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unicycive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Unicycive Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
